Atrás
35
También listada como
TCYMF
OTC
Rango del Día
$31.18
$32.77
Rango de 52 Semanas
$26.20
$37.30
Volumen
202
Promedio 50D / 200D
$32.34
/
$30.11
Cierre Anterior
$32.75
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Consumer Defensive (329 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 2.5 | 10.4 |
| P/B | 0.7 | 1.2 |
| ROE % | 26.6 | 12.6 |
| Net Margin % | 4.6 | 5.3 |
| Rev Growth 5Y % | 4.5 | 5.5 |
| D/E | 1.0 | 0.6 |
Puntos Clave
Revenue grew 4.50% annually over 5 years — modest growth
Earnings grew 19.79% over the past year
ROE of 26.56% indicates high profitability
Generating 4.66B in free cash flow
P/E of 2.46 — trading at a low valuation
PEG of 0.71 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
4.50%
Revenue (1Y)0.29%
Earnings (1Y)19.79%
FCF Growth (3Y)94.05%
Calidad
Return on Equity
26.56%
ROIC15.90%
Net Margin4.63%
Op. Margin7.29%
Seguridad
Debt / Equity
0.95
Current Ratio0.55
Interest Coverage13.90
Valoración
P/E Ratio
2.46
P/B Ratio0.65
EV/EBITDA2.58
Dividend Yield0.06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.29% | Revenue Growth (3Y) | 1.22% |
| Earnings Growth (1Y) | 19.79% | Earnings Growth (3Y) | 19.11% |
| Revenue Growth (5Y) | 4.50% | Earnings Growth (5Y) | -2.08% |
| Profitability | |||
| Revenue (TTM) | 80.65B | Net Income (TTM) | 3.73B |
| ROE | 26.56% | ROA | 7.03% |
| Gross Margin | 33.10% | Operating Margin | 7.29% |
| Net Margin | 4.63% | Free Cash Flow (TTM) | 4.66B |
| ROIC | 15.90% | FCF Growth (3Y) | 94.05% |
| Safety | |||
| Debt / Equity | 0.95 | Current Ratio | 0.55 |
| Interest Coverage | 13.90 | Dividend Yield | 0.06% |
| Valuation | |||
| P/E Ratio | 2.46 | P/B Ratio | 0.65 |
| P/S Ratio | 0.11 | PEG Ratio | 0.71 |
| EV/EBITDA | 2.58 | Dividend Yield | 0.06% |
| Market Cap | 9.20B | Enterprise Value | 15.20B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 80.65B | 80.42B | 78.72B | 74.08B | 67.62B |
| Net Income | 3.73B | 3.12B | 2.63B | 3.80B | 4.06B |
| EPS (Diluted) | 13.20 | 11.00 | 9.40 | 13.60 | 14.40 |
| Gross Profit | 26.70B | 24.47B | 22.90B | 22.51B | 22.43B |
| Operating Income | 5.88B | 3.91B | 3.33B | 4.33B | 5.99B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 53.15B | 53.15B | 58.45B | 60.31B | 61.53B |
| Total Liabilities | 35.53B | 35.93B | 41.63B | 37.90B | 36.79B |
| Shareholders' Equity | 14.23B | 13.89B | 13.37B | 18.66B | 21.11B |
| Total Debt | 13.52B | 14.06B | 17.92B | 14.02B | 14.01B |
| Cash & Equivalents | 7.52B | 6.75B | 12.32B | 15.84B | 21.39B |
| Current Assets | 17.99B | 20.47B | 24.03B | 25.67B | 28.70B |
| Current Liabilities | 32.42B | 29.19B | 31.70B | 29.83B | 27.07B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#273 of 658
Actividad Reciente
Entró
Contrarian Investing (David Dreman)
Mar 24, 2026